ITRM vs KEY
Iterum Therapeutics PLC (ITRM) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
ITRM currently screens at market cap $38.6M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the ITRM and KEY stock pages for the full models.
Not investment advice.